Vinzon Ibañez

561 total citations
23 papers, 300 citations indexed

About

Vinzon Ibañez is a scholar working on Genetics, Molecular Biology and Hematology. According to data from OpenAlex, Vinzon Ibañez has authored 23 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Genetics, 18 papers in Molecular Biology and 8 papers in Hematology. Recurrent topics in Vinzon Ibañez's work include Hemoglobinopathies and Related Disorders (21 papers), Epigenetics and DNA Methylation (16 papers) and Cancer-related gene regulation (7 papers). Vinzon Ibañez is often cited by papers focused on Hemoglobinopathies and Related Disorders (21 papers), Epigenetics and DNA Methylation (16 papers) and Cancer-related gene regulation (7 papers). Vinzon Ibañez collaborates with scholars based in United States and China. Vinzon Ibañez's co-authors include Donald Lavelle, Joseph DeSimone, Kestis Vaitkus, Angela Rivers, Maria Armila Ruiz, Ramasamy Jagadeeswaran, Yogen Saunthararajah, Tatiana Kouznetsova, Robert E. Molokie and James Douglas Engel and has published in prestigious journals such as Blood, PLoS ONE and Cancer Research.

In The Last Decade

Vinzon Ibañez

22 papers receiving 298 citations

Peers

Vinzon Ibañez
Shirley H. Purvis United States
Onima Chowdhury United Kingdom
K. G. Yang United States
Wattanan Makarasara Thailand
Flávia S. Donaires Brazil
Lea Shalmon Israel
Katayoon Shirneshan Germany
Kristin Johnson United States
Arthavan Selvanathan Australia
Senthil Raja Jayapal Singapore
Shirley H. Purvis United States
Vinzon Ibañez
Citations per year, relative to Vinzon Ibañez Vinzon Ibañez (= 1×) peers Shirley H. Purvis

Countries citing papers authored by Vinzon Ibañez

Since Specialization
Citations

This map shows the geographic impact of Vinzon Ibañez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vinzon Ibañez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vinzon Ibañez more than expected).

Fields of papers citing papers by Vinzon Ibañez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vinzon Ibañez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vinzon Ibañez. The network helps show where Vinzon Ibañez may publish in the future.

Co-authorship network of co-authors of Vinzon Ibañez

This figure shows the co-authorship network connecting the top 25 collaborators of Vinzon Ibañez. A scholar is included among the top collaborators of Vinzon Ibañez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vinzon Ibañez. Vinzon Ibañez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ibañez, Vinzon, Kestis Vaitkus, Maria Armila Ruiz, et al.. (2023). Effect of the LSD1 inhibitor RN-1 on γ-globin and global gene expression during erythroid differentiation in baboons (Papio anubis). PLoS ONE. 18(12). e0289860–e0289860.
2.
Ibañez, Vinzon, Kestis Vaitkus, Xu Zhang, et al.. (2023). Combinatorial targeting of epigenome-modifying enzymes with decitabine and RN-1 synergistically increases HbF. Blood Advances. 7(15). 3891–3902. 5 indexed citations
3.
Jagadeeswaran, Ramasamy, et al.. (2021). Nicotinamide Improves Anemia and Decreases Reactive Oxygen Species in Sickle Cell Disease Mice. Blood. 138(Supplement 1). 2019–2019. 2 indexed citations
4.
Jagadeeswaran, Ramasamy, Vinzon Ibañez, Baiyu Zhang, et al.. (2020). Cathepsin B, a Negative Regulator of Autophagy, Identified As a Novel Therapeutic Drug Target in Sickle Cell Disease. Blood. 136(Supplement 1). 32–32. 2 indexed citations
5.
Rivers, Angela, Kestis Vaitkus, Ramasamy Jagadeeswaran, et al.. (2018). Oral administration of the LSD1 inhibitor ORY-3001 increases fetal hemoglobin in sickle cell mice and baboons. Experimental Hematology. 67. 60–64.e2. 18 indexed citations
6.
Rivers, Angela, Kestis Vaitkus, Ramasamy Jagadeeswaran, et al.. (2017). Oral Administration of the LSD1 Inhibitor OG-S1335 Increases Fetal Hemoglobin in Humanized Transgenic Sickle Cell Disease Mice and in Baboons. Blood. 130. 356–356. 1 indexed citations
7.
Jagadeeswaran, Ramasamy, Muthusamy Thiruppathi, Balaji Ganesh, et al.. (2017). Pharmacological inhibition of LSD1 and mTOR reduces mitochondrial retention and associated ROS levels in the red blood cells of sickle cell disease. Experimental Hematology. 50. 46–52. 64 indexed citations
8.
Jagadeeswaran, Ramasamy, Vinzon Ibañez, Maria Armila Ruiz, et al.. (2016). Mitophagy Induction Is a Potential Therapeutic Approach for Sickle Cell Disease. Blood. 128(22). 267–267. 1 indexed citations
9.
Molokie, Robert E., Donald Lavelle, Michel Gowhari, et al.. (2016). Phase 1 Evaluation of Oral Tetrahydrouridine-Decitabine As Non-Cytotoxic Epigenetic Disease Modification for Sickle Cell Disease. Blood. 128(22). 124–124. 2 indexed citations
10.
Ruiz, Maria Armila, Angela Rivers, Vinzon Ibañez, et al.. (2015). Hydroxymethylcytosine and demethylation of theγ-globingene promoter during erythroid differentiation. Epigenetics. 10(5). 397–407. 23 indexed citations
11.
Rivers, Angela, Kestis Vaitkus, Maria Armila Ruiz, et al.. (2015). RN-1, a potent and selective lysine-specific demethylase 1 inhibitor, increases γ-globin expression, F reticulocytes, and F cells in a sickle cell disease mouse model. Experimental Hematology. 43(7). 546–553.e3. 37 indexed citations
12.
Jagadeeswaran, Ramasamy, Vinzon Ibañez, Maria Armila Ruiz, et al.. (2015). Investigation of Two Combination HbF Induction Regimens, RN-1 and Hydroxyurea Versus RN-1 and Decitabine, in a Humanized Sickle Cell Mouse Model. Blood. 126(23). 3386–3386. 3 indexed citations
13.
Rivers, Angela, Kestis Vaitkus, Maria Armila Ruiz, et al.. (2014). RN-1, a Potent and Selective LSD1 Inhibitor, Induces High Levels of Fetal Hemoglobin (HbF) in Anemic Baboons (P. anubis). Blood. 124(21). 336–336. 1 indexed citations
14.
Lavelle, Donald, Maria Armila Ruiz, Vinzon Ibañez, et al.. (2012). Effect of AGM and Fetal Liver-Derived Stromal Cell Lines on Globin Expression in Adult Baboon (P. anubis) Bone Marrow-Derived Erythroid Progenitors. PLoS ONE. 7(5). e36846–e36846. 6 indexed citations
15.
Akpan, Imo J., et al.. (2010). Decitabine increases fetal hemoglobin in Papio anubis by increasing γ-globin gene transcription. Experimental Hematology. 38(11). 989–993.e1. 21 indexed citations
16.
Ibañez, Vinzon, Kestis Vaitkus, Maria Armila Ruiz, et al.. (2010). siDNMT1 increases γ-globin expression in chemical inducer of dimerization (CID)−dependent mouse βYAC bone marrow cells and in baboon erythroid progenitor cell cultures. Experimental Hematology. 39(1). 26–36.e1. 22 indexed citations
17.
Singh, Mahipal, Kestis Vaitkus, Vinzon Ibañez, et al.. (2009). Transcriptional activation of the γ-globin gene in baboons treated with decitabine and in cultured erythroid progenitor cells involves different mechanisms. Experimental Hematology. 37(10). 1131–1142. 22 indexed citations
18.
Ibañez, Vinzon, et al.. (2008). The Role of DNA Damage/Stress Response Pathways in the Mechanism of Action of Decitabine. Blood. 112(11). 490–490. 1 indexed citations
19.
20.
Ibañez, Vinzon, Arun K. Sharma, Silvia Buonamici, et al.. (2004). AML1-ETO Decreases ETO-2 (MTG16) Interactions with Nuclear Receptor Corepressor, an Effect That Impairs Granulocyte Differentiation. Cancer Research. 64(13). 4547–4554. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shirley H. Purvis Breakdown of academic impact, for papers by Onima Chowdhury Breakdown of academic impact, for papers by K. G. Yang Breakdown of academic impact, for papers by Wattanan Makarasara Breakdown of academic impact, for papers by Flávia S. Donaires Breakdown of academic impact, for papers by Lea Shalmon Breakdown of academic impact, for papers by Katayoon Shirneshan Breakdown of academic impact, for papers by Kristin Johnson Breakdown of academic impact, for papers by Arthavan Selvanathan Breakdown of academic impact, for papers by Senthil Raja Jayapal
Rankless by CCL
2026